Cathy Wu at the Crossroads

Even standing still, Cathy H. Wu gives the impression of being on the move. In the foyer of the National Biomedical Research Foundation (NBRF) at Georgetown University, she listens while founder and president Robert S. Ledley tells an anecdote to a visitor. Wu, diminutive and neat in a lilac blouse and dark slacks, smiles and almost imperceptibly fidgets in place until it's time to lead a visitor away. Then she's off, veering around the corner toward the library like a commuter spotting a gap in

Written bySteve Bunk
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

She zips past some of the dozen staff in glass-fronted offices or workspaces formed by filing cabinets and bookshelves. Though no hulking IBMs or Crays crowd the corners of this modest basement office, it nevertheless houses the world's largest publicly available protein sequence database, called the Protein Information Resource (PIR).1 And since 1998, Wu has been its bioinformatics director.

Courtesy of Georgetown University Medical Center

Cathy Wu

For Wu, bioinformatics is an application. "You use a computer, databases, and software to help you solve more complicated biological problems." Trained in both molecular biology and computer science, she is particularly suited to cast biological questions in computational terms, so that appropriate algorithms can be written and programs developed. In so doing, Wu has made major strides toward transforming the PIR from a venerable organization struggling to cope with too much new data and too little computer science, into a burgeoning state-of-the-art ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies